Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 255

Similar articles for PubMed (Select 12499279)


Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK, Milas L.

Cancer Res. 2002 Dec 15;62(24):7350-6.


Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy.

Buchholz TA, Tu X, Ang KK, Esteva FJ, Kuerer HM, Pusztai L, Cristofanilli M, Singletary SE, Hortobagyi GN, Sahin AA.

Cancer. 2005 Aug 15;104(4):676-81.


Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.

Gaffney DK, Haslam D, Tsodikov A, Hammond E, Seaman J, Holden J, Lee RJ, Zempolich K, Dodson M.

Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):922-8.


Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.

Hitt R, Ciruelos E, Amador ML, Benito A, Sanchez JJ, Ballestin C, Cortes-Funes H.

Eur J Cancer. 2005 Feb;41(3):453-60.


Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ.

J Natl Cancer Inst. 1998 Jun 3;90(11):824-32.


Prognostic significance of EGF receptor expression in early glottic cancer.

Demiral AN, Sarioglu S, Birlik B, Sen M, Kinay M.

Auris Nasus Larynx. 2004 Dec;31(4):417-24.


Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.

Parise Junior O, Carvalho LV, Miguel RE, Kowalski LP.

Sao Paulo Med J. 2004 Nov 4;122(6):264-8. Epub 2005 Feb 2.


Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.

Psyrri A, Yu Z, Weinberger PM, Sasaki C, Haffty B, Camp R, Rimm D, Burtness BA.

Clin Cancer Res. 2005 Aug 15;11(16):5856-62.


Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma.

Chung CH, Zhang Q, Hammond EM, Trotti AM 3rd, Wang H, Spencer S, Zhang HZ, Cooper J, Jordan R, Rotman MH, Ang KK.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):331-8. doi: 10.1016/j.ijrobp.2010.05.024. Epub 2010 Aug 21.


Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.

Ozyar E, Gurkaynak M, Yildiz F, Atahan IL.

Radiother Oncol. 2004 Jul;72(1):71-7.


Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.

Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT.

Cancer. 2007 Feb 15;109(4):658-67. Erratum in: Cancer. 2009 May 1;115(9):2024. Reseetkova, Erika [corrected to Resetkova, Erika].


High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.

Ludovini V, Bellezza G, Pistola L, Bianconi F, Di Carlo L, Sidoni A, Semeraro A, Del Sordo R, Tofanetti FR, Mameli MG, Daddi G, Cavaliere A, Tonato M, Crinò L.

Ann Oncol. 2009 May;20(5):842-9. doi: 10.1093/annonc/mdn727. Epub 2009 Jan 19.


Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution.

Frata P, Buglione M, Grisanti S, Bonetti B, Vitali E, De Stefani A, Magri E, Peveri A, Marini G, Rossi G, Magrini SM.

Tumori. 2005 Nov-Dec;91(6):456-62.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk